Health officials have advised the White House that regulators need more time to review necessary data before approving a COVID-19 booster shot plan.
The guidance from the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) is that both agencies have so far only accumulated enough data to suggest that some individuals who received the Pfizer vaccine should get a booster shot.